Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$24,059,593
+$23,303,296 QoQ
Shares Held
94,734
+2961.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#662
of 4,664 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Diversify Advisory Services, LLC holds $87,794,871 across 13 Drug Manufacturers - General names. JNJ ranks #1 (27.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
94,734 | $24,059,593 | |
| 2 | LLY |
ELI LILLY & Co
|
16,684 | $20,011,291 | |
| 3 | ABBV |
AbbVie Inc.
|
64,821 | $16,311,556 | |
| 4 | AMGN |
Amgen Inc
|
22,302 | $8,076,000 | |
| 5 | MRK |
Merck & Co., Inc.
|
29,135 | $3,743,847 | |
| 6 | NVS |
Novartis AG
|
20,054 | $3,142,862 | |
| 7 | PFE |
Pfizer Inc
|
117,466 | $2,828,581 | |
| 8 | GSK |
GSK plc
|
43,867 | $2,299,508 |
All Filings in JNJ
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,059,593 | 94,734 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $756,297 | 3,094 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $11,852,647 | 57,273 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $10,889,345 | 58,728 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,438,728 | 61,792 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,557,344 | 51,600 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $7,734,422 | 53,481 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $9,356,534 | 57,735 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $8,705,143 | 59,559 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $9,437,299 | 59,658 | Shares | Sole | 2024-04-30 | |
| No filing history on record for this holder in this stock. | ||||||